In vitro microvessels for the study of angiogenesis and thrombosis

Microvascular networks support metabolic activity and define microenvironmental conditions within tissues in health and pathology. Recapitulation of functional microvascular structures in vitro could provide a platform for the study of complex vascular phenomena, including angiogenesis and thrombosis. We have engineered living microvascular networks in three-dimensional tissue scaffolds and demonstrated their biofunctionality in vitro. We describe the lithographic technique used to form endothelialized microfluidic vessels within a native collagen matrix; we characterize the morphology, mass transfer processes, and long-term stability of the endothelium; we elucidate the angiogenic activities of the endothelia and differential interactions with perivascular cells seeded in the collagen bulk; and we demonstrate the nonthrombotic nature of the vascular endothelium and its transition to a prothrombotic state during an inflammatory response. The success of these microvascular networks in recapitulating these phenomena points to the broad potential of this platform for the study of cardiovascular biology and pathophysiology.

[1]  T. Imaizumi,et al.  Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. , 2005, Current pharmaceutical design.

[2]  G. H. Nelson,et al.  Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo. , 1996, Stroke.

[3]  H. Granger,et al.  Integrin binding to fibronectin and vitronectin maintains the barrier function of isolated porcine coronary venules , 2001, The Journal of physiology.

[4]  H. Bunn.  Pathogenesis and treatment of sickle cell disease. , 1997, The New England journal of medicine.

[5]  F. Sasaki,et al.  Caveolar and intercellular channels provide major transport pathways of macromolecules across vascular endothelial cells , 2001, The Anatomical record.

[6]  B. Geiger,et al.  Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells , 1994, The Journal of cell biology.

[7]  L. Griffith,et al.  Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.

[8]  R. Gerrity,et al.  Endothelial cell morphology in areas of in vivo Evans blue uptake in the aorta of young pigs. II. Ultrastructure of the intima in areas of differing permeability to proteins. , 1977, The American journal of pathology.

[9]  S. Rich,et al.  Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension , 2003, Journal of cardiovascular pharmacology.

[10]  D. Wagner,et al.  The vessel wall and its interactions. , 2008, Blood.

[11]  Amber N. Stratman,et al.  Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. , 2009, Blood.

[12]  K. Piez,et al.  Collagen fibril formation. Optimal in vitro conditions and preliminary kinetic results. , 1978, The Journal of biological chemistry.

[13]  D. Vittet,et al.  In Vitro Models of Vasculogenesis and Angiogenesis , 2001, Laboratory Investigation.

[14]  Joe Tien,et al.  Fabrication of microfluidic hydrogels using molded gelatin as a sacrificial element. , 2007, Lab on a chip.

[15]  Z. Ruggeri,et al.  Activation of Platelet Function Through G Protein–Coupled Receptors Platelets As Immune Cells: Bridging Inflammation and Cardiovascular Disease In Vivo Thrombus Formation in Murine Models Clinical Aspects of Platelet Inhibitors and Thrombus Formation Adhesion Mechanisms in Platelet Function , 2007 .

[16]  L. Bonassar,et al.  Dense type I collagen matrices that support cellular remodeling and microfabrication for studies of tumor angiogenesis and vasculogenesis in vitro. , 2010, Biomaterials.

[17]  Jianhua Huang,et al.  A Role for VEGF as a Negative Regulator of Pericyte Function and Vessel Maturation , 2008, Nature.

[18]  A. Chauhan,et al.  Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. , 2005, The Journal of clinical investigation.

[19]  Jason P. Gleghorn,et al.  Microfluidic scaffolds for tissue engineering. , 2007, Nature materials.

[20]  J. Lewis,et al.  Omnidirectional Printing of 3D Microvascular Networks , 2011, Advanced materials.

[21]  Robyn Roth,et al.  Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress. , 2009, Blood.

[22]  Kazuo Fujikawa,et al.  ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. , 2002, Blood.

[23]  S Chien,et al.  Effects of disturbed flow on endothelial cells. , 1998, Journal of biomechanical engineering.

[24]  D. McDonald,et al.  Significance of blood vessel leakiness in cancer. , 2002, Cancer research.

[25]  J. Moake,et al.  N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. , 2011, The Journal of clinical investigation.

[26]  Napoleone Ferrara,et al.  Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. , 2005, Biochemical and biophysical research communications.

[27]  James G Truslow,et al.  The role of cyclic AMP in normalizing the function of engineered human blood microvessels in microfluidic collagen gels. , 2010, Biomaterials.

[28]  Dai Fukumura,et al.  Tissue engineering: Creation of long-lasting blood vessels , 2004, Nature.

[29]  Xueqian Wang,et al.  CNS Microvascular Pericytes Exhibit Multipotential Stem Cell Activity , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[31]  Russell Hughes,et al.  Current methods for assaying angiogenesis in vitro and in vivo , 2004, International journal of experimental pathology.

[32]  D. Deykin,et al.  Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. , 1982, The New England journal of medicine.

[33]  M. Bissell,et al.  Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. , 2006, Annual review of cell and developmental biology.

[34]  E. Battegay,et al.  Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects , 1995, Journal of Molecular Medicine.

[35]  James G Truslow,et al.  Effect of mechanical factors on the function of engineered human blood microvessels in microfluidic collagen gels. , 2010, Biomaterials.

[36]  E. Dejana,et al.  Perspectives Series: Cell Adhesion in Vascular Biology Endothelial Adherens Junctions: Implications in the Control of Vascular Permeability and Angiogenesis , 1996 .

[37]  A. Federici,et al.  Activation-independent platelet adhesion and aggregation under elevated shear stress. , 2005, Blood.

[38]  A. Malik,et al.  Signaling mechanisms regulating endothelial permeability. , 2006, Physiological reviews.

[39]  Lance L. Munn,et al.  Fluid forces control endothelial sprouting , 2011, Proceedings of the National Academy of Sciences.

[40]  Douglas A Lauffenburger,et al.  Microarchitecture of three-dimensional scaffolds influences cell migration behavior via junction interactions. , 2008, Biophysical journal.

[41]  D. Kohane,et al.  Engineering vascularized skeletal muscle tissue , 2005, Nature Biotechnology.

[42]  Claudia Fischbach,et al.  Microfluidic culture models of tumor angiogenesis. , 2010, Tissue engineering. Part A.

[43]  Kayla J Bayless,et al.  Sphingosine-1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices. , 2003, Biochemical and biophysical research communications.

[44]  M. Dickinson,et al.  The Effects of Hemodynamic Force on Embryonic Development , 2010, Microcirculation.

[45]  Kazuki Kobayashi,et al.  Control of endothelial sprouting by a Tel–CtBP complex , 2010, Nature Cell Biology.

[46]  J. Haorah,et al.  Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions , 2006, Journal of Neuroimmune Pharmacology.

[47]  B. Fu,et al.  Non-invasive measurement of solute permeability in cerebral microvessels of the rat. , 2009, Microvascular research.

[48]  Joe Tien,et al.  Formation of perfused, functional microvascular tubes in vitro. , 2006, Microvascular research.

[49]  Junmei Chen,et al.  Pathophysiology of venous thrombosis. , 2009, Thrombosis research.

[50]  R. Gerrity,et al.  Endothelial cell morphology in focal areas of in vivo Evans blue uptake in the young pig aorta. I. Quantitative light microscopic findings. , 1974, Experimental and molecular pathology.

[51]  C. Breuer,et al.  Vascular tissue engineering: the next generation. , 2012, Trends in molecular medicine.